Low and Declining Rate of 4-Class ARV Resistance Among Treatment-Experienced Patients in the EuResist Database

Clinical Care Options (CCO) presents a woman’s perspective on managing the long-term effects of HIV, antiretroviral therapy, and aging

Anonymous Patient Released: January 11, 2022

From Dr. Fidelia Bernice and Clinical Care Options (CCO), expert commentary on managing polypharmacy in people with HIV

Fidelia Bernice, PharmD Released: January 6, 2022

Dr John Baxter and Clinical Care Options (CCO): Proviral genotyping may help to inform ART choice in patients with suppressed HIV-1 RNA, particularly if preexisting resistance is suspected

John D. Baxter, MD Released: December 29, 2021

Dr Karen Ha and Clinical Care Options (CCO): Data suggests there is a role for PIs in current practice for rapid initiation and experienced patients

Karen Ha, MD Released: December 27, 2021